A Case Report of Sedation Strategy for a Patient With Coronavirus Disease 2019 Supported by Extracorporeal Membrane Oxygenation After Cesarean Section

Authors

  • Xiaozu Liao, MD Department of Anesthesiology, Zhongshan City People’s Hospital, Zhongshan, China
  • Zhou Cheng, MD Department of Anesthesiology, Zhongshan City People’s Hospital, Zhongshan, China
  • Junlin Wen, MD Department of Anesthesiology, Zhongshan City People’s Hospital, Zhongshan, China
  • Binfei Li, MD Department of Anesthesiology, Zhongshan City People’s Hospital, Zhongshan, China

DOI:

https://doi.org/10.1532/hsf.3459

Keywords:

COVID-19, Extracorporeal membrane oxygenation, Sedation strategy

Abstract

Pneumonia caused by coronavirus disease 2019 (COVID-19) is a highly contagious disease. Unfortunately, research on extracorporeal membrane oxygenation (ECMO) assisted treatments for patients with COVID-19 infection is limited. In this case study, a patient who was in late pregnancy (35+2 weeks of pregnancy) and suffering from severe COVID-19 was extremely irritable during ECMO-assisted treatment after she underwent a cesarean section. Her Richmond Agitation Sedation Scale (RASS) score reached +3. Nevertheless, the patient successfully was treated with a continuous single/combined application of propofol, midazolam, dexmedetomidine, hibernation mixture, and other drugs for several days (maintaining RASS -2 to -4) and provided with anti-infection, mechanical ventilation, nutritional support, fluid balance under hemodynamic monitoring, liver support, and other organ function support treatments. ECMO-assisted sedation strategy for patients was introduced and discussed in this case to provide a certain reference for the clinical diagnosis and treatment of such patients.

References

Balzer F, Weiß B, Kumpf O, et al. 2015. Early deep sedation is associated with decreased in-hospital and two-year follow-up survival. Critical Care. 19(1): 197.

Baron R, Binder A, Biniek R, et al. 2015. Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015)–short version. GMS German Medical Science. 13.

Celis-Rodríguez E, Birchenall C, de la Cal M, et al. 2013. Federación Panamericana e Ibérica de Sociedades de Medicina Crítica y Terapia Intensiva. Clinical practice guidelines for evidence-based management of sedoanalgesia in critically ill adult patients. Med Intensiva. 37(8): 519-574.

deBacker J, Tamberg E, Munshi L, et al. 2018. Sedation Practice in Extracorporeal Membrane Oxygenation–Treated Patients with Acute Respiratory Distress Syndrome: A Retrospective Study. Asaio Journal. 64(4): 544-551.

DeGrado JR, Hohlfelder B, Ritchie BM, et al. 2017. Evaluation of sedatives, analgesics, and neuromuscular blocking agents in adults receiving extracorporeal membrane oxygenation. Journal of critical care. 37(1-6).

Fisser C, Lüdtke P, Lubnow M, et al. 2019. Effect of tracheotomy on sedation, ventilation and ECMO adjustments in patients with acute respiratory failure on venovenous ECMO: a 10-year analysis [M]. Eur Respiratory Soc.

Hammaren E, Rosenberg P, Hynynen M. 1999. Coating of extracorporeal circuit with heparin does not prevent sequestration of propofol in vitro. British journal of anaesthesia. 82(1): 38-40.

Jackson DL, Proudfoot CW, Cann KF, et al. 2010. A systematic review of the impact of sedation practice in the ICU on resource use, costs and patient safety. Critical Care, 14(2): R59.

Lal A, Nabzdyk C, Ramakrishna H, et al. 2019. Consider Heightened Awareness of Propofol Infusion Syndrome after Extracorporeal Membrane Oxygenation (ECMO) Decannulation. Journal of Cardiothoracic and Vascular Anesthesia.

Meiser A, Bomberg H, Lepper P M, et al. 2017. Inhaled sedation in patients with acute respiratory distress syndrome undergoing extracorporeal membrane oxygenation. Anesthesia & Analgesia. 125(4): 1235-1239.

Shehabi Y, Bellomo R, Reade M, et al. 2012. Sedation Practice in Intensive Care Evaluation (SPICE) Study Investigators; ANZICS Clinical Trials Group. Early intensive care sedation predicts long-term mortality in ventilated critically ill patients. Am J Respir Crit Care Med. 186(8): 724-731.

Shekar K, Grewal J, Sutt A L, et al. 2019. Individualizing sedation in acute respiratory distress syndrome patients on extracorporeal membrane oxygenation. Asaio Journal. 65(4): e44-e45.

Shekar K, Roberts J, Ghassabian S, et al. 2012. Sedation during extracorporeal membrane oxygenation—why more is less. Anaesthesia and intensive care. 40(6): 1067-1069.

Shekar K, Roberts JA, Mcdonald CI, et al. 2015. Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo study. Critical Care. 19(1): 164.

Shekar K, Roberts JA, Mullany DV, et al. 2012. Increased sedation requirements in patients receiving extracorporeal membrane oxygenation for respiratory and cardiorespiratory failure. Anaesthesia and intensive care. 40(4): 648-655.

Published

2021-01-14

How to Cite

Liao, X., Cheng, Z., Wen, J., & Li, B. (2021). A Case Report of Sedation Strategy for a Patient With Coronavirus Disease 2019 Supported by Extracorporeal Membrane Oxygenation After Cesarean Section. The Heart Surgery Forum, 24(1), E019-E021. https://doi.org/10.1532/hsf.3459

Issue

Section

Articles